Investors & Media
Ionis is a sustainably profitable, multi-product company with a pipeline of more than 40 first-in-class and/or best-in-class medicines. We have created an efficient, broadly applicable, proprietary technology platform with the potential to treat diseases where no other therapeutic approaches have proven effective or ever existed. We continue to lead the way in RNA-targeted drug discovery and development of transformational medicines.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
“Because we can transform the treatment of a disease, we will always choose YES. No patient ever got better with a no.”